Posts Tagged 'zofran mdl'

Judicial Panel to Decide on Zofran MDL

zofran mdl status left to judicial panelThe U.S. Judicial Panel on Multidistrict litigation held a hearing on October 1 to help decide whether or not it will consolidate all pending federal Zofran birth defect lawsuits in a multidistrict litigation.

Zofran is an antiemetic drug used to prevent nausea and vomiting in patients who have undergone surgery, radiation therapy, or chemotherapy. While Zofran is not approved by the U.S. Food and Drug Administration for treatment of morning ...

continue reading...

North Dakota Couple Claim Zofran Caused Birth Defects

A North Dakota couple has filed a Zofran birth defect lawsuit claiming GlaxoSmithKline’s anti-nausea drug caused their child to be born with birth defects. The new filing is just one of a number of similar Zofran lawsuits that both plaintiffs and the defendant are trying to have consolidated into a multi district litigation or MDL.

Zofran is an antiemetic drug approved for use in patients experiencing nausea or vomiting after chemotherapy, radiation therapy, or surgery. The drug has not been ...

continue reading...

Zofran Maker Wants MDL for Birth Defect Lawsuits

GSK asks for Zofran MDLReuters reports that Zofran maker GlaxoSmithKline has asked the U.S. Judicial Panel on Multidistrict Litigation to centralize all pending Zofran birth defect lawsuits in a multidistrict litigation. The pharmaceutical giant has requested the Zofran lawsuits be consolidated in federal court in Pennsylvania, near the company’s U.S. headquarters.

Zofran is an antiemetic drug used to treat nausea and vomiting in chemotherapy, radiation therapy, and surgery patients. Zofran is also frequently prescribed to ...

continue reading...